Back

AAV9-mediated delivery of a NFAT decoy oligonucleotide prevents pathological myocardial hypertrophy and heart failure in mice

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms Experimental Heart Failure ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Anca Remes

Christian-Albrechts-University Kiel, Kiel (Germany)

21 More presentations in this session

Presentation thumbnail
Effects of mineralocorticoid receptor antagonists on diastolic function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials
Associate Professor H. Fukuta (Nagoya, JP)
Abstract
Presentation thumbnail
Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction
Doctor K. Kopeva (Tomsk, RU)
Abstract Slides
Presentation thumbnail
Astragaloside IV reduces cardiac oxidation and improves left ventricular diastolic dysfunction
Doctor Q. Wang (Lanzhou, CN)
Abstract
Presentation thumbnail
Long non coding RNA levels in hypertensive patients with heart failure with preserved ejection fraction and their relation to their functional capacity
Associate Professor M. Marketou (Heraklion, GR)
Abstract Slides
Presentation thumbnail
Morphological and functional changes in cardiovascular system in heart failure with preserved ejection fraction.
Doctor M. Kurkina (Moscow, RU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Coronary microvascular dysfunction in heart failure: observations from the MICRO registry
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources